Choosing an online tirzepatide service: a decision record
Build a decision record before choosing an online tirzepatide service. Start with the exact proposed product, then give the clinical discussion, dispensing arrangements and payment commitment their own spaces. The worksheet below helps keep those questions together without merging their answers.
Use the [provider comparison](/reviews/compare) for the financial record and the [ElixaMD review](/reviews/elixamd-review) for that provider’s document review. Read each linked review with its own date and scope; use this guide to organize the questions you bring forward.
. November 5, 2026: added product context and an original decision record. Featured offer examples retain their October 5, 2026 review date.
Start with the proposed product
Give every proposed option a separate record. Copy its complete name and presentation, then record who supplied that description and when. If a subsequent message changes the product, start a new version instead of carrying the old description forward.
Put the product document beside the commercial quote. Mark any mismatch between their names as a question to resolve. It does not select a treatment or turn a budget comparison into a clinical recommendation.
Bring the clinical question into focus
The August 2026 Zepbound label describes subcutaneous tirzepatide with reduced-calorie eating and increased activity: weight management for adults with obesity, or overweight plus a weight-related condition; also moderate-to-severe obstructive sleep apnea in adults with obesity. Contraindications include personal/family history of medullary thyroid carcinoma, MEN2 and serious allergy to tirzepatide or its ingredients. Discuss other medicines, pregnancy and planned anesthesia with your clinician. These selected points are not complete safety guidance, personal clearance or approval of compounded preparations.
Sources: Label
Check the dispensing record
FDA recommends checking that an online pharmacy requires a prescription, offers pharmacist access and is licensed through a state pharmacy board. Verify the named pharmacy in the board’s database; this guide does not verify any listed service.
FDA also explains that compounded drugs lack FDA approval and its premarket review of safety, effectiveness and quality. That general distinction is not a finding about a particular provider.
Sources: Pharmacies · Compounding
Use one record for the conversation
Complete this record for each option. Keep exact names and dated answers in your private notes, and give unanswered items an owner: the person or organization from whom you need a reply. Do not submit personal medical details to a comparison publisher.
Avoid a points total. One answered billing question cannot cancel out an unanswered clinical question. Instead, identify the next decision, the information needed for it and the person who can address it.
| Decision area | What to record | Useful next question |
|---|---|---|
| Product identity | Exact proposed name and document date | Does every document refer to this selection? |
| Clinical discussion | Named contact and questions still open | Who will explain the assessment and next step? |
| Dispensing record | Named organization and its reply | Which details are confirmed for this order? |
| Follow-up | Contact route and expected response process | What should I do if I receive no reply? |
| Payment decision | Amount, date and what it authorizes | What remains conditional before I commit? |
| Unresolved item | Question, recipient and date sent | What answer would let me proceed with this decision? |
Prepare for a useful discussion
Use the medication-list worksheet to organize what you want to bring to the clinical conversation. Keep a separate page for your goals, concerns and questions. Leave space beside each question for the answer and the next step agreed during the discussion.
Write questions in your own words rather than trying to make your notes sound like a medical record. For example: “What information do you still need from me?” and “How will you communicate the decision?” If an answer introduces an unfamiliar term, ask for an explanation before marking the question complete. Your notes should help you follow the conversation, not score your own eligibility.
Plan the follow-up before committing
Trace three ordinary questions through the proposed arrangement: a question for the clinician, a question about the order and a question about a charge. Record the route given for each, including any stated response process. If the same entry point handles all three, ask how it directs your question to the right person.
Add a fallback question: “What should I do if this route does not produce a response?” Keep the answer beside the primary contact. This creates a usable contact plan rather than a list of logos. It does not establish how quickly a service will respond in practice.
On the financial sheet, distinguish requesting an order, authorizing a payment and receiving confirmation of the next step. Ask which event each message records. Keep the exact status instead of relabeling every acknowledgement as approval.
Use research for the right question
For further reading, open our existing tirzepatide research article and semaglutide research article. Read their methods and limitations alongside their figures. These are separate reading destinations, not a new comparison of the services listed here.
Keep a research question on the research page and an offer question on the offer sheet. Before carrying a conclusion between them, identify the product, people and question it concerns.
Finish with a brief decision note: the option under consideration, documents reviewed, unresolved items and next conversation. Date it. When an answer arrives, update the relevant item and retain the earlier version so that you can see what changed.
Questions to resolve
What if the proposed product changes during the process?
Start a new version of the record with the revised name and the date you received it. Reconcile the clinical discussion, order description and quote against that version before treating earlier answers as applicable. Ask which answers need to be revisited.
How do I compare follow-up arrangements without testing a service?
Record the written contact routes and response process, then list what you still need to know. Keep those descriptions separate from observed performance. A clear document can help you plan a question; it does not establish the experience you will have.
Does completing the worksheet mean I am eligible?
No. The worksheet organizes questions and documents for a professional conversation. It does not decide whether a medicine is appropriate for you. Bring the unanswered clinical items to the clinician rather than interpreting a complete-looking form as a decision.
A useful choice record makes the next step specific: one identified option, the relevant documents and a clear list of decisions still to be addressed.
Sources and limits
- Label
Reviewed for this update.
- Pharmacies
Reviewed for this update.
- Compounding
Reviewed for this update.
This educational update does not assess an individual, verify a provider’s licenses or independently test follow-up. Its brief product context is not the full prescribing information.

At a Glance
| # | Provider | Price | What that covers | Best for |
|---|---|---|---|---|
| 1 | CoreAge Rx | From $129/mo | Supplied annual equivalent; full term $1,548 | Comparing a supplied annual offer and the order policy |
| 2 | SuperHealthy Rx | From $135/mo | Linked monthly promotion; routine visit, medication and shipping | Understanding a monthly supply and refill choice |
| 3 | Likeness Rx | From $129/mo | Lowest twelve-month equivalent; full term $1,548 | Comparing several term lengths |
Featured offers checked October 5, 2026; CoreAge annual figures come from the supplied price sheet. Other entries retain the source context in their linked reviews. Confirm the selected offer before payment.
How We Ranked These
This is our publisher reading order, beginning with CoreAge Rx, SuperHealthy Rx and Likeness Rx. It is not a clinical ranking or a guarantee that the first entry has the smallest immediate payment. We distinguish named offers, complete commitments and questions that remain for the provider.
The named offer
Record the medication, duration and complete selected commitment. Keep supplied quotes separate from different public offers.
The prescription pathway
Identify the clinical team and dispensing pharmacy for the actual order; a platform label does not establish every participant.
The next payment
Record renewal dates, refill choices and order-processing cutoffs before authorizing a commitment.
The evidence boundary
Provider marketing and published policies are sources to assess, not proof of pharmacy quality or treatment outcomes.
What we could not assess
- •The three featured offers were checked October 5, 2026. Other reviewed options retain the price context and source dates in their linked reviews.
- •We did not make a test purchase, inspect a pharmacy or measure clinical outcomes.
- •Publisher preference scores do not represent patient-review averages or establish clinically superior care.
CoreAge Rx
4.9 / 5
Our recommended starting point
Why it ranks here
CoreAge offers a documented route from intake to prescribing review and pharmacy fulfillment. The supplied annual figure needs to be kept separate from its public product-page starting offer. Read the complete term, included services and order policy before applying the price to a clinical plan.
The catch
The lowest supplied annual equivalent and the public starting offers are not interchangeable. Confirm the actual term, quantity and payment schedule.
SuperHealthy Rx
4.8 / 5
Second in our reading order
Why it ranks here
The named SuperHealthy promotion states a monthly supply price and describes automatic refill as optional after the first order. That makes the refill decision worth comparing with an automatically renewing term. The review distinguishes this landing page from the main website’s different general headline.
The catch
The main website and linked promotion need to be kept distinct. Save the offer actually selected.
Likeness Rx
4.7 / 5
Third in our reading order
Why it ranks here
Likeness makes one-, three-, six- and twelve-month terms visible in its plan selector. The lower monthly equivalents describe larger complete commitments. Its FAQ states that the selected term renews automatically and the first refill is billed early, so the next charge date is part of the comparison.
The catch
A reader wanting only one month should compare the one-month offer, not the twelve-month equivalent.
Which One Fits Your Situation?
Use the questions that match the proposed service and payment arrangement. The reading order does not determine which treatment is appropriate.
You want to understand the complete term
Use the term explorer and retain the relevant offer record.
You need the provider’s policy details
Read the full CoreAge review before applying the supplied annual figure to an order.
You want to compare refill arrangements
Read the SuperHealthy and Likeness reviews; optional refill and automatic term renewal are different arrangements.
🇺🇸Medical Disclaimer
Your health, your doctor. This ranking is information about services, not medical advice, and we are researchers rather than clinicians. GLP-1 medications are prescription drugs requiring physician oversight and are not appropriate for everyone. Which medication suits you — if any — is a decision for you and your healthcare provider, not a function of which company ranks first here. Individual responses vary significantly. Verified October 5, 2026.
Read the underlying sources
The full reviews include additional product pages and policy details. The CoreAge annual sheet is separate from its public product-page offers.